miR-486-5p has been detected in various cancer cells [30,31], and its overexpression inhibits cell proliferation in leukemia cells, through targeting forkhead box protein O1 (FOXO1) [32], and accelerates anti-proliferative effects via PIM-1 in breast cancer cells [33]. Here, FOXO1 is linked to breast cancer.